RaySearch Laboratories AB (publ) Cash Flow Conversion Efficiency
RaySearch Laboratories AB (publ) cash flow conversion efficiency. Based on the latest financial reports, RaySearch Laboratories AB (publ) (RAY-B) has a cash flow conversion efficiency ratio of 0.169x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr133.30 Million ≈ $14.35 Million USD) by net assets (Skr788.30 Million ≈ $84.83 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of RaySearch Laboratories AB (publ) (2003–2025)
Cash flow conversion efficiency of RaySearch Laboratories AB (publ) from 2003 to 2025. This chart illustrates how RaySearch Laboratories AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest RaySearch Laboratories AB (publ) stock price today for real-time trading data and today's change.
RaySearch Laboratories AB (publ) Cash Flow Conversion Ratio Explained
RaySearch Laboratories AB (publ) cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
RaySearch Laboratories AB (publ) Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of RaySearch Laboratories AB (publ) ranked by their cash flow conversion efficiency. Also see how much is RaySearch Laboratories AB (publ) worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Nanfang Black Sesame Group Co Ltd
SHE:000716
|
0.049x |
|
M Grass Ecology and Environment Group Co Ltd
SHE:300355
|
0.125x |
|
SIS LIMITED
NSE:SIS
|
0.063x |
|
Autohellas S.A.
AT:OTOEL
|
0.064x |
|
Zhang Xiaoquan Inc.
SHE:301055
|
N/A |
|
Shenzhen Liande Automatic Equipment Co Ltd
SHE:300545
|
-0.012x |
|
SeaBird Exploration Plc
OL:SBX
|
0.148x |
|
Guangzhou Lushan New Materials Co. Ltd.
SHG:603051
|
N/A |
Annual Cash Flow Conversion Efficiency for RaySearch Laboratories AB (publ) (2003–2025)
The table below shows the annual cash flow conversion efficiency of RaySearch Laboratories AB (publ) from 2003 to 2025. Review RaySearch Laboratories AB (publ) free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr985.30 Million ≈ $106.03 Million |
Skr387.00 Million ≈ $41.65 Million |
0.393x | -29.03% |
| 2024-12-31 | Skr876.71 Million ≈ $94.35 Million |
Skr485.23 Million ≈ $52.22 Million |
0.553x | -10.75% |
| 2023-12-31 | Skr735.23 Million ≈ $79.12 Million |
Skr455.93 Million ≈ $49.07 Million |
0.620x | +14.22% |
| 2022-12-31 | Skr657.16 Million ≈ $70.72 Million |
Skr356.78 Million ≈ $38.39 Million |
0.543x | +48.01% |
| 2021-12-31 | Skr649.28 Million ≈ $69.87 Million |
Skr238.16 Million ≈ $25.63 Million |
0.367x | -23.17% |
| 2020-12-31 | Skr694.35 Million ≈ $74.72 Million |
Skr331.51 Million ≈ $35.68 Million |
0.477x | +5.21% |
| 2019-12-31 | Skr705.47 Million ≈ $75.92 Million |
Skr320.14 Million ≈ $34.45 Million |
0.454x | +67.17% |
| 2018-12-31 | Skr657.45 Million ≈ $70.75 Million |
Skr178.47 Million ≈ $19.21 Million |
0.271x | +6.84% |
| 2017-12-31 | Skr580.42 Million ≈ $62.46 Million |
Skr147.48 Million ≈ $15.87 Million |
0.254x | -3.24% |
| 2016-12-31 | Skr460.19 Million ≈ $49.52 Million |
Skr120.85 Million ≈ $13.01 Million |
0.263x | -24.70% |
| 2015-12-31 | Skr319.52 Million ≈ $34.39 Million |
Skr111.43 Million ≈ $11.99 Million |
0.349x | +74.49% |
| 2014-12-31 | Skr251.55 Million ≈ $27.07 Million |
Skr50.27 Million ≈ $5.41 Million |
0.200x | +25.60% |
| 2013-12-31 | Skr196.60 Million ≈ $21.16 Million |
Skr31.28 Million ≈ $3.37 Million |
0.159x | -60.42% |
| 2012-12-31 | Skr217.55 Million ≈ $23.41 Million |
Skr87.45 Million ≈ $9.41 Million |
0.402x | +133.57% |
| 2011-12-31 | Skr196.70 Million ≈ $21.17 Million |
Skr33.85 Million ≈ $3.64 Million |
0.172x | -46.06% |
| 2010-12-31 | Skr196.76 Million ≈ $21.17 Million |
Skr62.78 Million ≈ $6.76 Million |
0.319x | +19.87% |
| 2009-12-31 | Skr184.86 Million ≈ $19.89 Million |
Skr49.21 Million ≈ $5.30 Million |
0.266x | +53.75% |
| 2008-12-31 | Skr150.44 Million ≈ $16.19 Million |
Skr26.05 Million ≈ $2.80 Million |
0.173x | -36.96% |
| 2007-12-31 | Skr137.85 Million ≈ $14.83 Million |
Skr37.86 Million ≈ $4.07 Million |
0.275x | +7.77% |
| 2006-12-31 | Skr118.07 Million ≈ $12.71 Million |
Skr30.09 Million ≈ $3.24 Million |
0.255x | -49.60% |
| 2005-12-31 | Skr81.85 Million ≈ $8.81 Million |
Skr41.39 Million ≈ $4.45 Million |
0.506x | +28.56% |
| 2004-12-31 | Skr32.72 Million ≈ $3.52 Million |
Skr12.87 Million ≈ $1.39 Million |
0.393x | +11.83% |
| 2003-12-31 | Skr19.82 Million ≈ $2.13 Million |
Skr6.97 Million ≈ $750.30K |
0.352x | -- |
About RaySearch Laboratories AB (publ)
RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. It offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a treatment co… Read more